Classification of Cell-in-Cell Structures: Different Phenomena with Similar Appearance.

adhesion molecules cancer cell cannibalism cell-in-cell emperipolesis enclysis entosis phagoptosis

Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
28 09 2021
Historique:
received: 25 08 2021
revised: 21 09 2021
accepted: 22 09 2021
entrez: 23 10 2021
pubmed: 24 10 2021
medline: 6 1 2022
Statut: epublish

Résumé

A phenomenon known for over 100 years named "cell-in-cell" (CIC) is now undergoing its renaissance, mostly due to modern cell visualization techniques. It is no longer an esoteric process studied by a few cell biologists, as there is increasing evidence that CICs may have prognostic and diagnostic value for cancer patients. There are many unresolved questions stemming from the difficulties in studying CICs and the limitations of current molecular techniques. CIC formation involves a dynamic interaction between an outer or engulfing cell and an inner or engulfed cell, which can be of the same (homotypic) or different kind (heterotypic). Either one of those cells appears to be able to initiate this process, which involves signaling through cell-cell adhesion, followed by cytoskeleton activation, leading to the deformation of the cellular membrane and movements of both cells that subsequently result in CICs. This review focuses on the distinction of five known forms of CIC (cell cannibalism, phagoptosis, enclysis, entosis, and emperipolesis), their unique features, characteristics, and underlying molecular mechanisms.

Identifiants

pubmed: 34685548
pii: cells10102569
doi: 10.3390/cells10102569
pmc: PMC8534218
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Warszawski Uniwersytet Medyczny
ID : 1M15/1/M/MG/N/21
Organisme : Warszawski Uniwersytet Medyczny
ID : 1M15/4/M/MG/N/21

Références

Nat Rev Cancer. 2019 Oct;19(10):568-586
pubmed: 31462760
Front Cell Dev Biol. 2019 Dec 03;7:311
pubmed: 31850347
Elife. 2019 May 01;8:
pubmed: 31042146
Front Oncol. 2019 Dec 19;9:1444
pubmed: 31921689
Cancers (Basel). 2020 Sep 01;12(9):
pubmed: 32883000
Elife. 2014 Jun 20;3:
pubmed: 24950964
Exp Oncol. 2012 Oct;34(3):306-11
pubmed: 23070016
Nat Cell Biol. 2011 Oct 16;13(11):1335-43
pubmed: 22002674
Trends Biochem Sci. 2012 Aug;37(8):325-32
pubmed: 22682109
Oncol Lett. 2019 Mar;17(3):3151-3162
pubmed: 30867745
Proc Natl Acad Sci U S A. 2015 Feb 17;112(7):2145-50
pubmed: 25646432
Lab Invest. 2003 Nov;83(11):1555-67
pubmed: 14615410
Front Immunol. 2020 May 13;11:650
pubmed: 32528462
Nature. 2017 May 25;545(7655):495-499
pubmed: 28514441
Biochemistry (Mosc). 2015 Nov;80(11):1469-77
pubmed: 26615438
PLoS One. 2013;8(3):e59418
pubmed: 23555668
Postepy Biochem. 2018 Oct 15;64(2):110-118
pubmed: 30656893
Mol Biol Cell. 2012 Jun;23(11):2076-91
pubmed: 22496418
Biomed Res Int. 2015;2015:359392
pubmed: 26504802
Cancer Res. 2012 Apr 1;72(7):1596-601
pubmed: 22447569
Cell Death Dis. 2010 Oct 21;1:e87
pubmed: 21368860
Transfusion. 2007 Sep;47(9):1725-32
pubmed: 17725740
Oncogene. 2015 Oct 1;34(40):5163-74
pubmed: 25659576
Cell Res. 2008 Jul;18(7):705-7
pubmed: 18521104
FEBS J. 2018 Oct;285(19):3566-3575
pubmed: 29125686
Nat Immunol. 2018 Jan;19(1):76-84
pubmed: 29180808
Science. 2000 Jun 16;288(5473):2051-4
pubmed: 10856220
Toxicol In Vitro. 2021 Jun;73:105144
pubmed: 33722735
MAbs. 2015;7(2):311-21
pubmed: 25760767
Sci Rep. 2017 Oct 2;7(1):12555
pubmed: 28970591
Cell Death Differ. 2021 Feb;28(2):799-813
pubmed: 33110215
Methods Mol Biol. 2008;445:77-88
pubmed: 18425443
Semin Cancer Biol. 2021 Mar 13;:
pubmed: 33727077
Proc Natl Acad Sci U S A. 2011 Oct 4;108(40):16735-40
pubmed: 21933957
Cell Rep. 2020 Aug 25;32(8):108071
pubmed: 32846129
Glia. 2014 Sep;62(9):1463-75
pubmed: 24838858
Diagn Cytopathol. 2003 Feb;28(2):86-7
pubmed: 12561027
Cell Rep. 2017 Jul 5;20(1):201-210
pubmed: 28683313
Cancer Lett. 2007 Dec 18;258(2):155-64
pubmed: 17977647
J Biol Chem. 2001 Jan 12;276(2):1071-7
pubmed: 10986279
J Cell Biol. 2019 Nov 4;218(11):3827-3844
pubmed: 31530580
Dev Cell. 2016 Sep 12;38(5):536-47
pubmed: 27623384
iScience. 2021 Jul 24;24(8):102902
pubmed: 34401679
Cell Death Dis. 2021 Jan 22;12(1):119
pubmed: 33483474
Nat Rev Cancer. 2018 Dec;18(12):758-766
pubmed: 30420767
J Cell Biol. 2017 Oct 2;216(10):3087-3095
pubmed: 28774893
Cell Death Differ. 2021 Sep;28(9):2765-2777
pubmed: 33879858
J Neurochem. 2013 Aug;126(3):312-7
pubmed: 23647050
Sci Rep. 2021 Aug 16;11(1):16539
pubmed: 34400683
Mod Pathol. 2020 Sep;33(9):1822-1831
pubmed: 32350415
J Sci Food Agric. 2011 Aug 15;91(10):1810-3
pubmed: 21452172
Int J Oncol. 2010 Dec;37(6):1361-78
pubmed: 21042704
Cell Res. 2014 Nov;24(11):1299-310
pubmed: 25342560
Philos Trans R Soc Lond B Biol Sci. 2019 Feb 4;374(1765):20180154
pubmed: 30967004
Cell Rep. 2019 Nov 5;29(6):1610-1620.e4
pubmed: 31693899
Methods Mol Biol. 2019;1880:447-454
pubmed: 30610714
Philos Trans R Soc Lond B Biol Sci. 2019 Feb 4;374(1765):20180285
pubmed: 30967008
PLoS One. 2020 Apr 2;15(4):e0231003
pubmed: 32240238
Cancer Control. 2014 Oct;21(4):322-7
pubmed: 25310213
Cancer Res. 2015 Dec 1;75(23):5008-13
pubmed: 26573795
Curr Mol Med. 2015;15(9):828-35
pubmed: 26511706
Curr Opin Cell Biol. 2020 Apr;63:1-10
pubmed: 31901645
Oncotarget. 2017 Jun 15;8(37):60892-60903
pubmed: 28977832
Cell. 2007 Nov 30;131(5):966-79
pubmed: 18045538
Clin Rev Allergy Immunol. 2015 Jun;48(2-3):226-35
pubmed: 25051956
Front Immunol. 2021 Apr 19;12:662134
pubmed: 33953725
EMBO Rep. 2009 Dec;10(12):1348-54
pubmed: 19893578
EMBO Mol Med. 2012 Sep;4(9):964-79
pubmed: 22821859
Cell Death Differ. 2018 Feb;25(2):368-379
pubmed: 29125601
Int J Mol Sci. 2018 Sep 20;19(10):
pubmed: 30241340
Cancer Res. 2006 Apr 1;66(7):3629-38
pubmed: 16585188
J Immunol. 2011 Apr 15;186(8):4973-83
pubmed: 21402900
Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):E6447-E6456
pubmed: 27698134
Diagn Pathol. 2015 Aug 27;10:149
pubmed: 26307067
Br J Haematol. 1956 Jul;2(3):283-94
pubmed: 13342362
Cell Death Dis. 2018 Jan 24;9(2):95
pubmed: 29367622
Hepatology. 2018 Sep;68(3):1025-1041
pubmed: 29603348
J Biol Chem. 2003 Oct 17;278(42):41282-93
pubmed: 12853445
J Clin Invest. 2016 Jul 1;126(7):2610-20
pubmed: 27294525
Cell Death Dis. 2013 Oct 10;4:e856
pubmed: 24113190
Front Oncol. 2021 Jun 11;11:670051
pubmed: 34178655
Oncotarget. 2017 Aug 9;8(35):57934-57935
pubmed: 28938526
Blood. 2013 Nov 14;122(20):3482-91
pubmed: 24106207
BMC Mol Cell Biol. 2021 Jul 31;22(1):39
pubmed: 34332531
J Dig Dis. 2021 Jun;22(6):351-362
pubmed: 33928766
Nat Commun. 2018 Aug 3;9(1):3070
pubmed: 30076358
Curr Mol Med. 2015;15(9):836-41
pubmed: 26511709
Radiat Oncol. 2017 Jan 18;12(1):21
pubmed: 28100275
EBioMedicine. 2017 Aug;22:89-99
pubmed: 28733045
Nat Cell Biol. 2011 Mar;13(3):324-30
pubmed: 21336303
Front Oncol. 2019 Sep 20;9:895
pubmed: 31681557
J Biol Chem. 2011 Nov 18;286(46):39904-13
pubmed: 21903584
Cell Death Differ. 2018 Mar;25(3):486-541
pubmed: 29362479
Med Res Rev. 2021 May 6;:
pubmed: 33957000
Immunol Rev. 2009 Jan;227(1):203-20
pubmed: 19120486
Int J Cancer. 2009 Nov 15;125(10):2239-45
pubmed: 19588507
Elife. 2017 Jul 11;6:
pubmed: 28693721
J Breast Cancer. 2016 Sep;19(3):231-241
pubmed: 27721872
J Biol Chem. 2007 Mar 16;282(11):8498-509
pubmed: 17229723
Front Immunol. 2020 Jul 07;11:1144
pubmed: 32733436
Cell Res. 2015 Jul;25(7):785-800
pubmed: 25916549

Auteurs

Karol Borensztejn (K)

Histology and Embryology Students' Science Association, Department of Histology and Embryology, Faculty of Medicine, Warsaw Medical University, Chalubinskiego 5, 02-004 Warsaw, Poland.

Paweł Tyrna (P)

Histology and Embryology Students' Science Association, Department of Histology and Embryology, Faculty of Medicine, Warsaw Medical University, Chalubinskiego 5, 02-004 Warsaw, Poland.

Agata M Gaweł (AM)

Histology and Embryology Students' Science Association, Department of Histology and Embryology, Faculty of Medicine, Warsaw Medical University, Chalubinskiego 5, 02-004 Warsaw, Poland.

Ireneusz Dziuba (I)

Faculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszyński University in Warsaw, Dewajtis 5, 01-815 Warsaw, Poland.
Faculty of Medicine, University of Technology, Rolna 43, 40-555 Katowice, Poland.

Cezary Wojcik (C)

US Cardiovascular, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320-1799, USA.

Lukasz P Bialy (LP)

Department of Histology and Embryology, Faculty of Medicine, Warsaw Medical University, Chalubinskiego 5, 02-004 Warsaw, Poland.

Izabela Mlynarczuk-Bialy (I)

Department of Histology and Embryology, Faculty of Medicine, Warsaw Medical University, Chalubinskiego 5, 02-004 Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH